Gotowa bibliografia na temat „TP53 polymorphism”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „TP53 polymorphism”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "TP53 polymorphism"
Dabre, Soayebo, Abdou Azaque Zoure, Touwendpoulimdé Isabelle Kiendrébéogo, et al. "Involvement of p.R72P and PIN3 Ins16bp (TP53) Polymorphisms and the I157T (CHEK2) Mutation in Breast Cancer Occurrence in Burkina Faso." Asian Pacific Journal of Cancer Biology 8, no. 2 (2023): 135–45. http://dx.doi.org/10.31557/apjcb.2023.8.2.135-145.
Pełny tekst źródłaNishizuka, Satoshi, Yukimi Ohmori, Takeshi Iwaya, and Keisuke Koeda. "Recurrence risk evaluation in stage IB gastric cancer with TP53 codon 72 polymorphism." Journal of Clinical Oncology 37, no. 15_suppl (2019): 4044. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4044.
Pełny tekst źródłaDiakite, Brehima, Yaya Kassogue, Mamoudou Maiga, et al. "Abstract 7326: TP53 p.Pro47Ser polymorphism in breast cancer susceptibility in Mali." Cancer Research 84, no. 6_Supplement (2024): 7326. http://dx.doi.org/10.1158/1538-7445.am2024-7326.
Pełny tekst źródłaLiao, Fan, Li Yuan, Jinhong Zhu, Wei Chen, Yemu Zhao, and Jing He. "Association of TP53 rs1042522 C>G Polymorphism with Glioma Risk in Chinese Children." BioMed Research International 2022 (August 13, 2022): 1–6. http://dx.doi.org/10.1155/2022/2712808.
Pełny tekst źródłaMoe, Svein Erik, Fredrik A. Erland, Siren Fromreide, et al. "The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(−) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients." Biomedicines 11, no. 7 (2023): 1838. http://dx.doi.org/10.3390/biomedicines11071838.
Pełny tekst źródłaDeben, Christophe, Jolien Van den Bossche, Nele Van Der Steen, et al. "Deep sequencing of the TP53 gene reveals a potential risk allele for non–small cell lung cancer and supports the negative prognostic value of TP53 variants." Tumor Biology 39, no. 2 (2017): 101042831769432. http://dx.doi.org/10.1177/1010428317694327.
Pełny tekst źródłaIordanishvili, Saba, Tornike Metreveli, Elene Lipartia, et al. "The HPV-TP53-MALAT1 Axis: Unravelling interactions in cervical cancer development." PLOS ONE 18, no. 10 (2023): e0291725. http://dx.doi.org/10.1371/journal.pone.0291725.
Pełny tekst źródłaUsategui-Martín, Ricardo, Nadia Galindo-Cabello, Salvador Pastor-Idoate, et al. "A Missense Variant in TP53 Could Be a Genetic Biomarker Associated with Bone Tissue Alterations." International Journal of Molecular Sciences 25, no. 3 (2024): 1395. http://dx.doi.org/10.3390/ijms25031395.
Pełny tekst źródłaF. Fahmy, Nahed, Nagwa S. Ahmed, Ghada Galal, et al. "Study the Role of Tp53 in the Development of Hepatocellular Carcinoma in HCV Infected Patients." Egyptian Journal of Medical Microbiology EJMM29, no. 4 (2020): 165–72. http://dx.doi.org/10.51429/ejmm29421.
Pełny tekst źródłaMaiga, Mamoudou, Brehima Diakite, Yaya Kassogue, et al. "Abstract 7328: Relationship between PIN3 16bp duplication of TP53 and HPV in HIV women in Mali." Cancer Research 84, no. 6_Supplement (2024): 7328. http://dx.doi.org/10.1158/1538-7445.am2024-7328.
Pełny tekst źródłaRozprawy doktorskie na temat "TP53 polymorphism"
Silva, Ana Manoela Maria da. "ANÁLISE DO POLIMORFISMO DOS GENES TP53 E CYP1A1m1 EM BIÓPSIA DE ENDOMÉTRIO DE PACIENTES COM ENDOMETRIOSE." Pontifícia Universidade Católica de Goiás, 2012. http://localhost:8080/tede/handle/tede/2343.
Pełny tekst źródłaAlmeida, Priscilla Silva Rosa de. "POLIMORFISMO DO GENE TP53 EM SARCOMAS DE PARTES MOLES NO ADULTO." Pontifícia Universidade Católica de Goiás, 2008. http://localhost:8080/tede/handle/tede/2412.
Pełny tekst źródłaMelo, Márcia Portela de. "Análise do polimorfismo R72P do gene TP53 em paciente com carcinoma de mama ductal invasor." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2008. http://hdl.handle.net/10183/13063.
Pełny tekst źródłaCortezzi, Sylvia Sanches. "Papilomavírus humano e polimorfismo do gene TP53 no carcinoma espinocelular de cabeça e pescoço /." São José do Rio Preto : [s.n.], 2002. http://hdl.handle.net/11449/92507.
Pełny tekst źródłaFagundes, Simone Souza. "RELAÇÃO DO POLIMORFISMO DO GENE TP53 NO CÓDON 72 COM CÂNCER DE MAMA: UMA ATUALIZAÇÃO DE METANÁLISE (2002-2015)." Pontifícia Universidade Católica de Goiás, 2016. http://tede2.pucgoias.edu.br:8080/handle/tede/3524.
Pełny tekst źródłaCortezzi, Sylvia Sanches [UNESP]. "Papilomavírus humano e polimorfismo do gene TP53 no carcinoma espinocelular de cabeça e pescoço." Universidade Estadual Paulista (UNESP), 2002. http://hdl.handle.net/11449/92507.
Pełny tekst źródłaRibeiro, Eliane da Silva. "IMPORTÂNCIA DO HPV NO CARCINOMA DO COLO UTERINO E A ASSOCIAÇÃO COM O POLIMORFISMO R72P DO GENE TP53 E A RADIOTERAPIA." Pontifícia Universidade Católica de Goiás, 2012. http://localhost:8080/tede/handle/tede/2364.
Pełny tekst źródłaLima, Junior Mario Maciel de 1974. "Avaliação antropométrica, prostatica e polimorfismos de TP53 e GSTP1 em populações do estremo setentrional amazônico." [s.n.], 2012. http://repositorio.unicamp.br/jspui/handle/REPOSIP/310299.
Pełny tekst źródłaAchatz, Maria Isabel Alves de Souza Waddington. "Modificadores de penetrância de mutações germinativas no gene TP53 em famílias brasileiras com diagnóstico clínico da síndrome de Li-Fraumeni e Li-Fraumeni like: impacto dos polimorfismos intragênicos do TP53 e de genes." Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/5/5155/tde-29012009-172419/.
Pełny tekst źródłaPortari, Elyzabeth Avvad. "Estudo de polimorfismos nos genes TP53 e p21(WAF1) e do perfil imunohistoquímico das proteínas p53, p21(WAF1), p16(INK4a) e ciclina D1 pela técnica de Tissue Microarray (TMA) e sua importância para o desenvolvimento e/ou severidade das neoplasias cervicais." Universidade do Estado do Rio de Janeiro, 2012. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=9228.
Pełny tekst źródłaCzęści książek na temat "TP53 polymorphism"
V., Evgeny, Nadezhda V., Nicolay V., et al. "TP53 Gene Polymorphisms in Cancer Risk: The Modulating Effect of Ageing, Ethnicity and TP53 Somatic Abnormalities." In Tumor Suppressor Genes. InTech, 2012. http://dx.doi.org/10.5772/27768.
Pełny tekst źródłaStreszczenia konferencji na temat "TP53 polymorphism"
Santos, Igor Lopes dos, Nathalia Amaral Nogueira, Luciana Corrêa Amador, et al. "ANALYSIS OF THE R337H VARIANT IN THE TP53 GENE IN A GROUP OF PREMENOPAUSAL WOMEN WITH BREAST CANCER FROM THE CENTRALWESTERN REGION OF BRAZIL: A PILOT STUDY." In Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2053.
Pełny tekst źródłaRivera, Bianca L., Ricardo López, Roger Vázquez, Yarilis Castro, and Adriana Báez. "Abstract 1558: TP53 codon 72 polymorphism association with prognosis in Puerto Rican head and neck squamous cell carcinoma patients." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1558.
Pełny tekst źródłaFalk, Ingrid Jakobsen, Kerstin Willander, Roza Chaireti, et al. "Abstract 3518: TP53 mutations and MDM2 single nucleotide polymorphism 309T-G predicts outcome and treatment resistance in acute myeloid leukemia." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3518.
Pełny tekst źródłaShiraishi, Kouya, Hideo Kunitoh, Chiharu Tanai, et al. "Abstract C109: Association of TP53 gene polymorphism with response to platinum-based doublet chemotherapy in non-small cell lung cancer patients." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-c109.
Pełny tekst źródłaNOGAMI, P. Y., M. N. S. SILVA, I. B. COSTA, et al. "TP53 GENE PRO72ARG(RS1042522) SINGLE NUCLEOTIDE POLYMORPHISM IS ASSOCIATED WITH INCREASED RISK OF METASTASIS IN GASTRIC ADENOCARCINOMA IN THE AMAZON POPULATION." In ONCOLOGY 2023 International Symposium. Even3, 2025. https://doi.org/10.29327/oncology-2023-international-symposium.1084768.
Pełny tekst źródłaSamuel, Nardin, Ana Novokmet, Thomas J. Hudson, and David Malkin. "Abstract 16: Impact of germline TP53 mutations and polymorphisms in women with premenopausal breast cancer." In Abstracts: AACR Special Conference: Cancer Susceptibility and Cancer Susceptibility Syndromes; January 29-February 1, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.cansusc14-16.
Pełny tekst źródłaJadhav, Trafina, Jesus Salazar-Gonzalez, Shantel Hebert-Magee, et al. "Abstract 2776: Codon 72 and Intron-3 polymorphisms in TP53 are risk factors for breast cancer." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-2776.
Pełny tekst źródłaKuddus, Ruhul H., Asmahan A. El Ezzi, Mohammed A. El-Saidi, Scott Baker, and Wissam Zaidan. "Abstract 4821: Association of polymorphisms in TP53, CXCL2, MDM2, MDM4 and BCL2 genes and proliferative prostate diseases among Lebanese men." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4821.
Pełny tekst źródłaSouza, Cristabelle Madona N. de, Jeremy Chien, and Jill Madden. "Abstract B41: Studying the effect of germline polymorphisms on somatic hotspot mutations in TP53 for the treatment of high-grade serous ovarian carcinoma." In Abstracts: AACR Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment; October 1-4, 2017; Pittsburgh, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.ovca17-b41.
Pełny tekst źródłaRaporty organizacyjne na temat "TP53 polymorphism"
Jafrin, Sarah, Md Abdul Aziz, and Mohammad Safiqul Islam. Extended Investigation on the connection of TP73 G4C14-A4T14 Polymorphism with different Cancer Types – An Updated Meta-analysis with 56 Case-control Studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.1.0070.
Pełny tekst źródła